Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Cytotherapy
|
February 27, 2022
Long-term clinical efficacy of cytokine-induced killer cell-based immunotherapy in early-stage esophageal squamous cell carcinoma
Yanfen Liu, Zhen Zhang, Yonggui Tian, et al.
Histology and Histopathology
|
November 22, 2016
Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma
Xinfeng Chen, Liping Wang, Dongli Yue, et al.
Nature Immunology
|
November 3, 2023
Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1
Li Zhou, Dongxiao Wu, Yabo Zhou, et al.
Nature Immunology
|
November 7, 2023
Publisher Correction: Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1
Li Zhou, Dongxiao Wu, Yabo Zhou, et al.
International Journal of Cancer
|
July 8, 2018
Dual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8<sup>+</sup> T cell response in esophageal squamous cell carcinoma
Xinfeng Chen, Liping Wang, Pupu Li, et al.
Immunology Letters
|
March 26, 2019
The repertoire features of T cell receptor β-chain of different age and gender groups in healthy Chinese individuals
Jingyao Lian, Jianling Liu, Ying Yue, et al.
Cancer Immunology, Immunotherapy : CII
|
February 12, 2021
Regulatory T cells promote glioma cell stemness through TGF-β-NF-κB-IL6-STAT3 signaling
Shasha Liu, Chaoqi Zhang, Boqiao Wang, et al.
Cancer Immunology Research
|
August 8, 2018
Maelstrom Directs Myeloid-Derived Suppressor Cells to Promote Esophageal Squamous Cell Carcinoma Progression via Activation of the Akt1/RelA/IL8 Signaling Pathway
Pupu Li, Xinfeng Chen, Guohui Qin, et al.
Journal for Immunotherapy of Cancer
|
December 20, 2024
Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC
Yachang Huo, Dan Wang, Shuangning Yang, et al.
Cancer Research
|
January 28, 2018
Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
Lifeng Li, Liping Wang, Jieyao Li, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Cytotherapy
|
February 27, 2022
Long-term clinical efficacy of cytokine-induced killer cell-based immunotherapy in early-stage esophageal squamous cell carcinoma
Yanfen Liu, Zhen Zhang, Yonggui Tian, et al.
Histology and Histopathology
|
November 22, 2016
Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma
Xinfeng Chen, Liping Wang, Dongli Yue, et al.
Nature Immunology
|
November 3, 2023
Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1
Li Zhou, Dongxiao Wu, Yabo Zhou, et al.
Nature Immunology
|
November 7, 2023
Publisher Correction: Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1
Li Zhou, Dongxiao Wu, Yabo Zhou, et al.
International Journal of Cancer
|
July 8, 2018
Dual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8<sup>+</sup> T cell response in esophageal squamous cell carcinoma
Xinfeng Chen, Liping Wang, Pupu Li, et al.
Immunology Letters
|
March 26, 2019
The repertoire features of T cell receptor β-chain of different age and gender groups in healthy Chinese individuals
Jingyao Lian, Jianling Liu, Ying Yue, et al.
Cancer Immunology, Immunotherapy : CII
|
February 12, 2021
Regulatory T cells promote glioma cell stemness through TGF-β-NF-κB-IL6-STAT3 signaling
Shasha Liu, Chaoqi Zhang, Boqiao Wang, et al.
Cancer Immunology Research
|
August 8, 2018
Maelstrom Directs Myeloid-Derived Suppressor Cells to Promote Esophageal Squamous Cell Carcinoma Progression via Activation of the Akt1/RelA/IL8 Signaling Pathway
Pupu Li, Xinfeng Chen, Guohui Qin, et al.
Journal for Immunotherapy of Cancer
|
December 20, 2024
Optimal timing of anti-PD-1 antibody combined with chemotherapy administration in patients with NSCLC
Yachang Huo, Dan Wang, Shuangning Yang, et al.
Cancer Research
|
January 28, 2018
Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
Lifeng Li, Liping Wang, Jieyao Li, et al.
Page
of 6